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PART I - BACKGROUND 
 
1. INTRODUCTION 
 
1.1. Historical Aspects of Caffeine 
The alerting proprieties of caffeine and its possible beneficial effects on motor and cognitive 
performance have long been touted. Legend has it, in fact, that an observant goatherd named 
Kaldi discovered coffee in Ethiopia somewhere between about 300 and 800 A.D.. He noticed that 
his goats did not sleep at night after eating coffee berries, so he took the berries to a local abbot, 
who brewed the first batch of coffee, noting its effects on arousal and 
cognition and motor performance (Smith et al., 2002). Coffee spread from 
Ethiopia into the Arabic world, was brought to Venice in the early 17
th
 
century and became known in Europe during that century, at first as a 
medicine, and then as a social drink in the Arab tradition (Fredholm et al., 
1999).              Figure1. Friedrich Runge  
In 1819 the german chemist Friedrich Ferdinand Runge (figure 1 (http://www.shiga-med.ac.jp/~ 
koyama/pain/Runge.jpg)) isolated caffeine at the behest of Johann Wolfgang von Goethe. As in 
the work “Faust” by Goethe the soul of Faust has been sold to the devil in exchange for 
“jeunesse”, it appears that Goethe was anticipating in almost 200 years, the use of caffeine to treat 
diseases that predominate during ageing such as the case of the neurodegenerative diseases. 
The structure of caffeine was elucidated near the end of 19
th
 century by Herman Fischer (figures 2 
(http://www.nobel-winners.com/Chemistry/emil_hermann_fischer.jpg) and 3 (http://www.regator. 
  
com/blog/wp-content/uploads/2008/08/caffeine.jpg)(http://library.thinkquest.org/C0115926/drugs 
/Caffeine_2D_Structure_3541.gif)) (Ribeiro & Sebastião, 2009). 
    
Figure 2. . Herman Fischer    Figure 3. Caffeine structure 
 
Coffee has ever since been valued as stimulating the mind and sharpening the senses. Caffeine, 
the psycho-active substance responsible for these effects, may be the most consumed psycho-
active drug in the world (Fredholm et al., 1999). Caffeine is mainly present in coffee, which also 
contains trace amounts of theophylline, but no theobromine (Ribeiro & Sebastião, 2009). 
Almost all caffeine originates from dietary sources, such as soft and energy drinks, hot chocolate, 
certain food products like cakes and candies, and over-the-counter medications, including 
analgesics and cold remedies, with coffee and tea being the most popular (Brice and Smith, 2002). 
The content of caffeine in these food items ranges from 71 to 220 mg/150 ml for coffee to 32 to 
42 mg/150 ml for tea, 32 to 70 mg/330 ml for cola, and 4 mg/150 ml for cocoa (Debry, 1994). 
Consumption of coffee varies largely among different countries. The highest consumption (more 
than 10 kg/person/year) occurs in Scandinavia, Austria, and the Netherlands. In most western 
European countries, coffee consumption ranges from 6 to 9 kg/person/year. The lowest 
consumption (less than 5 kg/person/year) is found in the U.S. and Italy (D’Amicis and Viani, 
  
1993; Debry, 1994). Furthermore, the content of caffeine per cup of coffee varies with the size of 
the serving, the mode of preparation of coffee (boiled, filtered, percolated, espresso or instant), 
and the type of coffee, Arabica or Robusta (D’Amicis and Viani, 1993; Debry, 1994). The size of 
the cup ranges from 50 to 190 ml and the content of caffeine in a 150-ml cup of coffee is a low as 
19 mg/cup in instant coffee and as high as 177 mg/cup in boiled coffee. In Portugal, the volume of 
the cup ranges from 16 to 53 ml and the content of caffeine varies between 1,2 to 4,7 mg/ml 
depending the size of the cup (Casal et al., 2009). Caffeine consumption from all sources can be 
estimated as 76 mg/person/d but reaches 210 to 238mg/d in the U.S. and Canada, and more than 
400 mg/person/d in Sweden and Finland, where 80 to 100% of the caffeine intake comes only 
from coffee (Viani, 1993, 1996; Debry, 1994; Barone and Roberts, 1996). 
 
1.2. Metabolism 
Caffeine is metabolized in the liver by the cytochrome P450 oxidase enzyme system into three 
dimethylxanthines (figure 4 (http://www.psycheteria.org/iphone/CaffeineMetabolites.png)):  
paraxanthine (1,7-dimethylxanthine), which increases lipolysis, leading to elevated glycerol and 
free fatty acid levels in the blood plasma, theobromine, which dilates blood vessels and increases 
urine volume, and theophylline (1,3-dimethylxanthine), which relaxes smooth muscles of the 
bronchi (figure5 (http://journals.prous.com/journals/dot/20044001/html/dt400055/images/Hansel 
_f4.jpg)). The therapeutic dose of theophylline, however, is many times greater than the amount 
resulting from caffeine metabolism taking in non toxic amounts. Each of those xanthines is 
further metabolized and then excreted into the urine (Ribeiro and Sebastião, 2009). 
  
    
                 Figure 4. Caffeine metabolites          Figure 5. Theophylline actions 
 
It has been shown that, after long-term caffeine ingestion, the levels of theophylline in the mouse 
brain may be higher than those of caffeine during a substantial part of the day and almost always 
higher then the level of paraxanthine (Johansson et al., 1996). This could mean that caffeine in the 
brain is metabolized partly via specific, local enzymatic pathways and that caffeine administration 
leads to high CNS concentrations of theophylline, whereas peripheral theophylline levels are kept 
low (Fredholm et al., 1999). The contention that most of the effects of caffeine in the CNS are 
direct or indirect consequences of adenosine receptors blockade increases in strength if local CNS 
concentrations of theophylline and/or paraxanthine are high after caffeine ingestion, since 
theophylline is some three to five times more potent than caffeine as an inhibitor of both 
adenosine A1 and A2A receptors, and paraxanthine is also at least as potent as caffeine (Benowitz 
et al., 1995). 
Caffeine appears to be metabolized similarly in young and old individuals (Blanchard and Sawers, 
1983). However, due to the lower lean body mass in older people, the bioavailability of caffeine 
in this group may be higher and may lead to higher blood and tissue concentrations.  
  
The hydrophobic properties of caffeine allow its passage trough all biological membranes. 
Caffeine crosses the blood-brain barrier either in the adult or the young animal (Lachance et al., 
1983; Tanaka et al., 1984), and the blood-to-plasma ratio is close to unity (McCall et al., 1982), 
indicating limited plasma protein binding and free passage into blood cells. In newborn infants, 
caffeine concentration is similar in plasma and cerebrospinal fluid (Turmen et al., 1979; Somani 
et al., 1980). There is no placental barrier to caffeine (Ikeda et al., 1982; Kimmel et al., 1984) and 
unusually high levels of caffeine have been reported in premature infants born to women who are 
heavy caffeine consumers (Khanna and Somani, 1984). 
There is ample evidence that smokers metabolize caffeine by approximately 50% more rapidly 
than nonsmokers (Benowitz et al., 1989). Ex-smokers consume somewhat less caffeine than 
smokers (although more than nonsmokers), but they also metabolize the drug more slowly 
(Swanson et al., 1994), thus, the level of caffeine may be at least as high. The effects of caffeine 
are probably due to a mixture of caffeine, theophylline, and paraxanthine, and the changes in the 
total amount of active drug are not known. Therefore, the speculation (Swanson et al., 1994) that 
lowered metabolism of caffeine in ex-smokers may lead to increased toxicity remains 
unsubstantiated (Fredholm et al., 1999). 
Moreover, a relationship between adenosine A2A receptors antagonist and genetic variability in 
caffeine metabolism associated with habitual caffeine consumption has been proposed (Cornelis 
et al., 2007), which provides a biological basis for caffeine consumption. In this study, persons 
with ADORA2A TT genotype were significantly more likely to consume less caffeine than carriers 
of C allele. 
 
 
  
1.3. Therapeutic Use 
Caffeine and theophylline have been or are used as adjuncts or agents in medicinal formulations. 
Methylxanthines have been used to treat bronchial asthma (Serafin, 1996), apnea of infants 
(Bairam et al., 1987; Serafin, 1996), as cardiac stimulants (Ahmad and Watson, 1990), as 
diuretics (Eddy and Downes, 1928), as adjuncts with analgesics (Sawynok and Yaksh, 1993; 
Zhang, 2001), in electroconvulsive therapy (Coffey et al., 1990), and in combination with 
ergotamine for treatment of migraine (Diener et al., 2002). A herbal dietary supplement 
containing ephedrine and caffeine is used as an anorectic (Haller et al., 2002). Other potential 
therapeutic targets for caffeine include diabetes (Islam et al., 1998; Islam et al., 2002), 
parkinsonism (Schwarzschild et al., 2002), and even cancer (Lu et al., 2002). Caffeine has also 
been used as a diagnostic tool for malignant hyperthermia (Larach, 1989). 
 
1.4. Constituents of Coffee Other than Caffeine 
One of the major constituents of coffee, caffeic acid (figure 6 (http://www.agrool.gr/files/caffeic% 
20acid.jpg)) is an effective antioxidant agent (Reneva et al., 2001). It has been suggested that the 
antioxidant activity of caffeoyl derivates emanates from the ability of caffeic acid (figure 7 
(http://www.chemdrug.com/databases/dataimg/1/20.png)) to form an iron complex, which 
prevents the production of hydroxyl radicals (Kono et al., 1998; Sestili et al., 2002). It was 
demonstrated that the roasting process has no diminishing effect on the antioxidant activity of 
remaining caffeoyl derivates (Charurin et al., 2002). Because coffee contains a higher percentage 
of caffeic acid derivatives, such as chlorogenic acid and 1,3-dicaffeoyl quinic acid, than other 
beverages (Clifford, 2000; Mattila and Kumpilainen, 2002) the antioxidant effects and 
hepatoprotective activities must have been taken into account (Rechner et al., 2001). 
  
 
   
   Figure 6 – caffeic acid   Figure 7 - dihydrocaffeic acid 
 
1.5. Mechanisms of Action 
When we talk about caffeine actions on the peripheral and central nervous system, we must 
consider the major mechanism, blockade of adenosine receptors, in particular A1 and A2A 
adenosine receptors (see below). Other mechanisms should also be considered (figure 8 
(http://www.biology-online.org/user_files/Image/caffeineF01.gif)), namely blockade of 
phosphodiesterases (PDEs) (e.g., PDE1, PDE4, PDE5), regulating levels of cyclic nucleotides. 
These effects (up to 40% inhibition of phosphodiesterases) according to Daly (Daly, 2007) may 
be observed in concentrations below those that cause toxic effects. In relation to PDE5 inhibition, 
it is interesting to note that caffeine acts like sildenafil, a PDE5 inhibitor, thus, the potential 
effects related to these actions need to be investigated, to see whether consequent vasodilatation 
might contribute to the net effect of caffeine.  
Another mechanism involves actions on ion channels. Caffeine enhances the activity of a cyclic 
ADP- ribose-sensitive calcium release channel, the so called ryanodine-sensitive channel, thereby 
causing release of intracellular calcium from storage sites in the sarcoplasmic reticulum of muscle 
and the endoplasmic reticulum of other cells, including neuronal cells (MacPherson et al., 1991; 
Galione, 1994), Caffeine also acts on the receptors for the inhibitory neurotransmitters γ-
  
aminobutyric acid (GABA) and glycine (Fredholm, 1980; Daly, 1993; Nehlig and Debry, 1994; 
Fredholm et al., 1997, 1999; Daly and Fredholm, 1998). 
 
 
     Figure 8 – Mechanisms of action  
 
The effects of caffeine are biphasic. The stimulatory behavioral effects in humans (and rodents) 
become manifest with plasma levels of 5 to 20 µM, whereas higher doses are depressant. The 
only sites of action where caffeine would be expected to have major pharmacological effect at 
levels of 5 to 20 µM are the A1- and the A2A- adenosine receptors, where caffeine is a competitive 
antagonist (Daly and Fredholm, 1998). Major effects at other sites of action, such as 
phosphodiesterases (inhibition), GABA and glycine receptors (blockade), and intracellular 
calcium-release channels (sensitization to activation by calcium) would be expected to require at 
least tenfold higher levels of caffeine.  
 
 
  
1.6. Peripheral Effects  
Beyond activating the central nervous system (CNS), leading to behavioral, autonomic, and 
endocrine responses (Rall, 1980; Nehlig et al., 1992), caffeine also exerts effects peripherally, 
mediated by direct tissue effects along with hormonal and autonomic outputs. Caffeine increases 
circulating catecholamines and free fatty acids (Robertson et al., 1978; Pincomb et al., 1988). It 
also increases blood pressure, both at rest and during behavioral stress (Lane and Williams, 1985; 
Sung et al., 1990; James, 1993). Neuroprotective effects of coffee may be related to its estrogenic 
effects. In studies of dopaminergic neurons, estrogen appears to reduce the production of free 
radicals and protects against oxidative stress (Pita et al., 2002). 
 
1.7. Toxicity and Abuse 
Tolerance develops very quickly, after heavy doses e.g. tolerance to sleep disruption (400 mg of 
caffeine 3 times a day for 7 days), tolerance to subjective effects of caffeine (300 mg 3 times per 
day for 18 days). Withdrawal symptoms may appear (figure 9 (http://upload.wikimedia.org/ 
wikipedia/commons/thumb/c/c7/Main_side_effects_of_Caffeine.svg/526px-Main side_effects of_ 
Caffeine.svg.png)), including inability to concentrate, headache, irritability, drowsiness, insomnia 
and pain in the stomach, upper body, and joints (within 12 to 24 hours after discontinuation of 
caffeine intake, peak being at roughly 48 hours, and usually last from one to five days - the time 
required for the number of adenosine receptors in the brain to revert to “normal” levels) (Ribeiro 
and Sebastião, 2009). 
In humans, caffeine may cause a wide range of unpleasant physical and mental conditions 
including nervousness, irritability, tremulousness, muscle twitching (hyperreflexia), insomnia, 
respiratory alkalosis, and heart palpitations. Caffeine increases production of stomach acid, and 
  
high usage over time can lead to peptic ulcers, erosive esophagitis, gastroesophageal reflux 
disease (Ribeiro and Sebastião, 2009), feeling of weariness, weakness, and drowsiness; impaired 
concentration; fatigue and work difficulty; depression; anxiety; increased muscle tension; and 
occasionally tremor, nausea or vomiting (Griffiths et al., 1990; Silverman et al., 1992; Hughes et 
al., 1993; Nehling and Debry, 1994; Strain et al., 1994, 1995; Dews et al., 2002).  
  
      Figure 9 - withdrawal symptoms     Figure 10 - overuse 
 
Overuse and dependency (figure 10 (http://upload.wikimedia.org/wikipedia/commons/thumb/6/ 
66/Main_symptoms_of_Caffeine_overdose.svg/548px-Main_symptoms_of_Caffeine_overdose.s 
vg.png)) occurs after consumption of caffeine in large amounts, and in particular over extended 
periods of time, inducing caffeinism (toxic effects of caffeine often referred to at nonlethal 
levels). Convulsions and death can occur at levels above 300 µM. However, it cannot be excluded 
that subtle effects of 5 to 20 mM caffeine at sites of action other than adenosine receptor might 
have some relevance to both acute and chronic effects of caffeine. Extensive in vitro studies of the 
  
actions of caffeine at such sites are usually performed at concentrations of caffeine of 1 µM or 
more, clearly levels that in vivo are lethal (Daly and Fredholm, 1998). 
It should be mentioned that alteration of astrocytogenesis via A2A adenosine receptors blockade 
during brain development raises the possibility that postnatal caffeine treatment could have long-
term negative consequences on brain function, and should perhaps be avoided in breast-feeding 
mothers (Desfrere et al., 2007). 
 
1.8. Adenosine 
When we talk about the role that caffeine plays in the brain, we must refer their interaction with 
adenosine (figure 11 (http://wpcontent.answers.com/wikipedia/commons/thumb/5/53/Caffeine 
and adenosine.svg/350px-Caffeine_and_adenosine.svg.png)). As a result, the next lines are 
dedicated to describe briefly adenosine and its relation with caffeine on the nervous system. 
 
 
Figure 11 – Caffeine and adenosine molecules  
 
Adenosine exists in all cells, and is released apparently from all cells, including neurons and glia. 
Adenosine is consensually recognized as a very important substance in the homeostasis of the 
cells in the nervous system, elegantly named by Newby (1981) a “retaliatory metabolite”, or 
  
according to others “a signal of life” (Engler, 1991). However, adenosine is involved in cell death 
namely in prevention or induction of apoptosis (e.g. Di Iorio et al., 2002). 
Adenosine is able to regulate synaptic functioning through tuning and fine-tuning. Tuning 
synapses occurs when adenosine by activating its receptors is controlling e.g. the release of 
neurotransmitters by interfering with Ca
2+
 or other mechanisms directly related to 
neurotransmitter release (Ribeiro, 1994). In the case of fine-tuning adenosine is interfering with 
receptors for other neuromodulators (Sebastião and Ribeiro, 2000). 
Adenosine is produced ubiquitously, and its neuroactive properties are determined by the 
presence of specific receptors in discrete regions of the brain that are involved in higher-order 
processes (e.g., the hippocampus, a brain structure that is critical for memory formation). At 
present, four heptahelical, G-protein-coupled receptors for adenosine have been identified and 
named A1, A2A and A3 receptors (high affinity) and A2B receptors (low affinity) (Fredholm et al., 
1994). Of these subtypes, the rat A3 receptor was originally shown to be but little affected by 
many methylxanthines, including caffeine. In humans, the A3 receptor is blocked by caffeine with 
a KD of close to 80 M. Therefore, this receptor is not the best target for caffeine action in 
humans. The A2B receptor has been shown to require higher concentrations of adenosine for 
activation than those found in resting animal tissues. Thus, inhibition of adenosine actions at this 
receptor is similarly unlikely to provide an explanation the actions of caffeine under physiological 
conditions. Under pathophysiological conditions, however, A2B receptors are likely to be activated 
by endogenous adenosine and caffeine may then very well act also on these receptors. 
Although A3 and A2B receptors are unlikely to be important, A1 and A2A receptors are activated at 
the low basal adenosine concentrations measured in resting rat brain. Thus, these receptors are 
  
likely to be the major targets for caffeine and theophylline (Fredholm et al., 1999). The adenosine 
A1 receptor is highly expressed in brain cortex, cerebellum, hippocampus and dorsal horn of 
spinal cord (Ribeiro et al., 2003). The A2A adenosine receptor is expressed in the striato-pallidal 
GABAergic neurons, olfactory bulb and hippocampus (Cunha et al., 1994a, Sebastião and 
Ribeiro, 2009). A2B receptors are expressed in low levels in the brain (Dixon et al., 1996) and the 
adenosine A3 receptor has apparently intermediate levels of expression in the human cerebellum, 
hippocampus and low levels in the most of the brain (figure 12) (see Fredholm et al., 2001). 
 
   Figure 12 - Adenosine receptors distribution in the CNS (Sebastião and Ribeiro, 2009) 
 
Since adenosine is ubiquitously present in all cells, with receptors distributed in all brain cells; 
any imbalance of such a widespread system is expected to lead to neurological 
dysfunctions/diseases. Due to its ability to antagonize adenosine receptors, to cross readily the 
blood brain barrier and to its safety, caffeine has therapeutic potential in central nervous system 
dysfunctions (Ribeiro and Sebastião, 2009). 
 
  
1.9. Effect of Caffeine on the Nervous System 
As a pharmacological tool, caffeine is not very useful since its affinity for adenosine receptors is 
low and its selectivity towards the different adenosine receptors is also poor. Caffeine is an 
antagonist of all subtypes of adenosine receptors and chronic or acute intake of caffeine may 
affect adenosine receptors in different and even opposite ways. The therapeutic or adverse effects 
of caffeine are considerably different depending on whether it is administered chronic or acutely. 
Chronic caffeine intake, with increases plasma concentrations of adenosine (Conlay et al., 1997), 
may be neuroprotective. This is in contrast with the consequences of acutely antagonizing A1 
adenosine receptors (de Mendonça et al., 2000).  
The acute effects of caffeine are related to the adenosine A1 and A2A antagonism of caffeine in the 
brain, which in turn stimulates the release and turnover of several central neurotransmitter 
substances, including acetylcholine and noradrenaline (Nehlig et al., 1992; Fredholm et al., 1999). 
At this line, caffeine blocking of A1 adenosine receptors may increase the levels of 
catecholamines and serotonin (Fredholm, 1995). When acting as an adenosine receptor antagonist, 
caffeine is doing the opposite of adenosine receptors activation whenever the levels of 
endogenous adenosine are tonically activating receptors. So, caffeine, like does adenosine, is 
exerting effects on all brain areas (Ribeiro and Sebastião, 2009), such as, facilitating neuronal 
activity by increasing excitatory neurotransmitter release and lowering the threshold for neuronal 
activation (Phillis et al., 1979). Caffeine causes an increase in spontaneous electrical activity in 
noradrenaline-containing neurons (Grant et al., 1982), as well as an increase of serotonin 
concentrations in the serotonergic neurons of the raphe nuclei (Berkowicz et al., 1971). 
Chronic adenosine receptor antagonism with caffeine may also influence cognition and motor 
activity in a way that resembles the acute effects of adenosine receptor agonists (Jacobson et al., 
  
1996; Sebastião and Ribeiro, 2009). Such opposite actions of chronic versus acute treatment not 
only have important implications for the development of xanthine-based compounds as 
therapeutic agents but also constitute a frequent confounding parameter in research. Upregulation 
of A1 adenosine receptors after chronic adenosine receptor antagonism with xanthines does occur, 
but A2A adenosine receptors levels apparently do not change; in addition, there are changes in the 
levels of receptors for neurotransmitters with chronic administration of xanthines, namely a 
marked decrease in -adrenergic receptors and an increase in 5-HT and GABAA receptors 
(Jacobson et al., 1996, Sebastião and Ribeiro, 2009). The increased expression of A1 adenosine 
receptors in response to chronic antagonism of adenosine receptors by caffeine, as compared with 
A2A adenosine receptors, may lead to a shift in the A1/ A2A adenosine receptors balance after 
prolonged caffeine intake (Ferré, 2008, Sebastião and Ribeiro, 2009). Moreover, chronic caffeine 
treatment leads to modifications in the function of the A1R- A2AR heteromer and this may, in part, 
be the scientific basis for the strong tolerance to the psychomotor effects of chronic caffeine 
(Ciruela et al., 2006; Sebastião and Ribeiro, 2009). 
 
1.10. Overview of the Motor System Physiology 
In order to understand the effects of caffeine on the motor system, a brief review of this system is 
presented. 
The frontal lobe of each hemisphere is responsible for planning and initiating sequences of 
behavior. The frontal lobe is divided into a number of different regions, including prefrontal 
cortex, premotor cortex and primary motor cortex (figure 13). The function of the prefrontal 
cortex is to plan complex behaviors, but does not specify the precise movement that should be 
  
made. It simply specifies the goal toward which movements should be directed. The prefrontal 
cortex sends instructions to the premotor cortex, which produces complex sequences of 
movement appropriate to the task. If the premotor cortex is damaged, such sequences cannot be 
coordinated and the goal cannot be accomplished.  
Although the premotor cortex organizes movements, it does not specify the details of how each 
movement is to be carried out. Specifying the details is the responsibility of the primary motor 
cortex, which is responsible for executing skilled movements (Kolb and Whishaw, 2001). 
      
     Figure 13 – The frontal lobe (Kolb et al., 2001)     Figure 14 – The corticospinal tracts (Kolb et al., 2001) 
 
The posterior motor areas in the frontal cortex receive their main cortical input from the parietal 
lobe, and the anterior motor areas receive their main cortical connections from the prefrontal lobe. 
Many transcranial magnetic stimulation studies have focused on the intrinsic organization, output 
pathways, and function of a frontal motor region bordering the central sulcus. This region, called 
  
the primary motor cortex, is essentially equivalent to area F1 (nomenclature according to Matelli 
et al., 1985) in monkey cortex or to cytoarchitectonically defined Brodmann area 4 in humans. It 
contains the largest output neurons of the cortex, the Betz cells, and it is probably the single most 
important source of crossed direct corticospinal projections controlling hand movements. It is 
noteworthy that the other frontal motor areas – the dorsal premotor cortex (superior part of 
Brodmann area 6, monkey areas F2 and F7 (Matelli et al., 1985), the ventral premotor cortex 
(inferior part of Brodmann area 6 and Brodmann area 44, monkey areas F3 and F6 (Matelli et al., 
1985)) – also are important sources of corticospinal projections. A part of the dorsal premotor 
(F7) and a part of the mesial cortical area (F6) do not contain corticospinal neurons, but send their 
efferent projections exclusively to the brainstem.  
The large pyramidal cells in the motor cortex send their axons to the contralateral side of the 
spinal cord and are able to activate their target motoneurons directly, but a number of interneurons 
in the brainstem or spinal cord are also influenced. These long projection neurons are called 
corticospinal neurons.  
The corticospinal tract (figure 14) originates in primary and secondary motor cortices and are 
located on the precentral gyrus (figure 15) (Jones and Wise, 1977).  
 
Figure 15 – The association motor cortices (Nicholls et al., 2001) 
  
Cells from which the pathway originates are arranged in an orderly manner to form a somatotopic 
pattern in primary motor cortex – M1 (figure 16) (Porter and Sakamoto, 1998; Kaneko et al., 
1994). 
 
Figure 16 - Motor representation of the cerebral cortex (Nicholls et al., 2001) 
 
Corticospinal neurons of the arm region in M1 thus project to arm motoneurons in the spinal cord, 
as well as interneurons involved in the control of arm, hand and fingers. In addition to M1, other 
areas in the frontal lobe, such as supplementary motor area and prefrontal areas are involved in 
other aspects of motor coordination (Grillner, 2001).  
Sherrington (1910) called the spinal motoneurons the “final common path” because all the neural 
influences that have to do with movement or posture converge upon it. The major motoneurons of 
the spinal cord are called  motoneurons. When a motoneuron discharges, all the muscle fibers to 
which it is connected contract. The motor unit constitutes the elementary component of normal 
movement.  
When  motoneurons are activated to produce shortening of extrafusal muscle fibers, other 
motoneurons ( motoneurons) are also activated to cause contraction of the intrafusal fibres as 
well. These muscle receptors have fast conducting afferent axons that provide rapid feedback to 
  
the spinal cord and take part in the autoregulation of the motor output to a given muscle. Thus, 
fast muscle spindle afferents provide direct monosynaptic excitation to the -motoneurons that 
control the muscle in which the muscle spindle is located (Greer and Stein, 1990). In this way, the 
fusimotor system maintains the tension on the muscle spindle receptors over the full range of limb 
position, so that their sensitivity is undiminished. The fusimotor innervation of muscle spindles 
can be thought of as a “gain control” system, continually adjusting sensitivity to maintain 
dynamic range (Sears, 1964; Critchlow and von Euler, 1963; Greer and Stein, 1990).  
Motor units are classified as either slow (S) or fast (F) according to their twitch contraction time 
for a motor unit to develop peak force following a single spike. The speed of the twitch and the 
rate of relaxation depend on the muscle fiber types of the motor unit and their geometry within the 
muscle (Floeter, 2001). 
 
      Figure 17 – Contractile properties and fatigability of different motor unit types (S, FR and FF) (Burke et al., 1973) 
 
Many of the motor areas contain complete representations of body movements. By virtue of their 
distinctive connections, each motor area may be involved in different aspects of sensorimotor 
transformations, in motor planning, and in motor execution (Rizzolatti et al., 1998). Studies have 
  
revealed that the motor system creates internal representations of actions in addition to these 
classically accepted functions. The identification of parietofrontal circuits suggests that the motor 
system contains many functional units that act in parallel. A view of the motor system as being 
exclusively hierarchically and serially organized is no longer tenable based on a multitude of 
anatomical and physiological data (Classen, 2005). 
 
1.11. Transcranial Magnetic Stimulation (TMS) as a Tool to Investigate the Motor System  
TMS has been used to improve our understanding of the human motor system. TMS studies have 
provided information about cortical connectivity and sensorimotor transformations of the primary 
motor cortex in surprising detail, as also have successfully been extended to study motor areas 
outside the primary motor cortex and to address more complex cortical functions. 
TMS is based on electromagnetic induction (figure 18), which is described by Faraday’s law. A 
time-varying current in a primary circuit (TMS coil) induces an electrical field and consequently a 
current flow (eddy current) in a secondary circuit (brain). The changing current in the coil 
generates a magnetic field B(t), but the field itself has no effect on neuronal activation; the 
magnetic field merely mediates the interaction. The electrical field induced is proportional to the 
rate of change of B; no neural excitation occurs with slowly changing or stationary B. Because the 
tissue is transparent to the magnetic field in TMS, the scalp and the skull do not resist the field. 
.   
Figure 18 – Principles of transcranial magnetic stimulation (Ruohonen et al., 2005) 
  
 
Transcranial stimulation is thus based on applying an electrical field in the brain tissue. The 
electrical field drives ionic currents in the tissue, charging the capacitances of neuronal 
membranes and thereby triggering the firing neurons.  
The electromagnetic theory for TMS is well established and can be divided into three separated 
parts: the electrical operation of the stimulator circuit, the computation of the macroscopic 
electromagnetic fields being imposed on the brain due to current in the stimulator coil, and the 
detailed flow of current and buildup of charge on cellular membranes as result of imposing a 
macroscopic electric field in the brain.  
Different orientations and intensities of TMS can recruit different proportions of D and I waves.  
The D waves are caused by direct activation of pyramidal axons, whereas the I waves are thought 
to originate from the deep fiber system that is tangential to the cortex and that synaptically excites 
the pyramidal cells. Because D waves are the result of stimulation at the axon of pyramidal tract 
neurons, they are not greatly influenced by changes in the level of excitability within the gray 
matter of the cerebral cortex (Di Lazzaro et al., 1999). However, the situation is quite different for 
I waves, which are highly sensitive to the level of cortical excitability at the time the stimulus is 
given because they are synaptically induced. If we wish to use TMS to probe the excitability of 
motor cortex, we should try to employ it so that it induces the greatest proportion of I-waves 
volleys possible. 
The fact that TMS evokes a complex series of repetitive discharges in the pyramidal tract of 
neuronal population has several implications for the electromyographic (EMG) responses that are 
evoked. These differ from the conventional compound muscle action potentials (CMAPs) 
produced by peripheral nerve stimulation in two important ways. First, the motor evoked 
  
potentials (MEPs) are always smaller, longer than in duration, and more polyphasic than a 
CMAP. Second, the onset latency, amplitude, and threshold of an MEP change according to 
whether subjects are relaxed or active (Day et al., 1987; Thompson et al., 1987) (figure 19). 
 
Figure 19 - EMG recordings (Rothwell, 2005)  
 
The descending corticospinal volleys produced by TMS release excitatory postsynaptic potentials 
(EPSPs) at the motor neuron, and these develop over a period of several milliseconds, depending 
the number of I waves that has been evoked. Motor neurons are discharged asynchronously, and 
this leads to the longer duration MEP, especially at high intensities of stimulation. There can be 
cancellation between phases of motor units discharging at slightly different latencies. 
The different latencies of MEPs evoked in active and relaxed muscles result from the time taken 
for EPSPs to depolarize a motor neuron to its firing threshold (figure 20). At rest, a single EPSP 
(e.g. that produced by the arrival of a D-wave volley) may fail to rise a motor neuron threshold 
and discharge will have to wait the arrival of the I1 volley some 1.5 ms later. However, if the 
same stimulus is given during voluntary contractions, there will always be some motor neurons 
that are near enough to their firing threshold to be discharged on receipt of the first EPSP that 
arrives at the motor neuron pool. MEPs evoked in actively contracting muscles always have the 
shortest possible latency, whereas those evoked in subjects at rest usually have a longer latency.  
  
 
  
Figure 20 – Latency differences between responses  evoked in relaxed and active muscle (Rothwell, 2005) 
 
The difference in amplitude of MEPs at rest and during activation mainly results from increased 
excitability of spinal motor neurons during contraction. This means that a given amount of 
descending excitation will cause more spinal motor neurons to discharge during contraction, 
leading to a larger MEP. However, there is also some evidence that the response of pyramidal 
tract neurons to a TMS pulse increased during voluntary contraction (Di Lazzaro et al., 1999). 
This may occur because the pyramidal tract neurons are more excitable and more readily 
discharge by synaptic input from I-waves generators during the course of voluntary contraction 
compared with rest.  
The same factors contribute to the difference in threshold for evoking an MEP at rest and during 
contraction. The rest motor threshold (RMT) is always higher than the active motor threshold 
(AMT) because resting spinal (and cortical) motor neurons require more excitation to reach 
discharge threshold than during contraction. Some of the most important electrophysiological 
measurements obtained with TMS are briefly discussed below. 
 
  
1.11.1 Central Silence Period 
The cortical silent period (CSP) refers to an interruption of voluntary muscle contraction by 
electrical or magnetic stimulation of the motor cortex. Although the first shorter part of CSP can 
depend on peripheral mechanisms related to lower motor neuron inhibition, the larger last part 
depends on inhibitory cortical interneurons. It is currently thought is that it depends on GABA-B 
receptors, as derived from TMS-pharmacological studies (Inghillery et al., 1996). 
 
1.11.2. Corticomotor Threshold  
The corticomotor threshold (CMT) is the lowest stimulation intensity able to evoke a MEP of 
minimal size and is usually assessed in a small hand muscle. The CMT depends on the 
excitability of spinal motoneurons and motor cortex neurons (Mills, 1999). In theory, to define 
CMT, a minimal MEP should be elicited in 50% of the trials. In practice, the stimulus intensity is 
increased at 5% steps until reaching a level that induces approximately 100 V responses in about 
50% of 10 consecutive trials. There is a CMT at rest (i.e., resting threshold) and one during 
contraction (i.e., active threshold) that is lower. Distal muscles have a lower CMT than proximal 
ones. 
The CMT augments with increasing age (Rossini et al., 1992) and is enhanced by sodium or 
calcium channel blocking anticonvulsants (Ziemann et al. 1996) but not by drugs acting on 
GABA or glutamate transmission. The CMT is based on mechanisms different from those of the 
CSP, which it ideally complements when investigating disease mechanisms. The CMT, for 
example, is raised in advanced cases of ALS (Eisen et al. 1990), multiple sclerosis (MS) 
(Ravnborg et al., 1991), in spinal injury above the lesion (Macdonell and Donnan 1995), and it is 
  
reduced in early cases of ALS (Mills and Nithi, 1997), idiopathic generalized epilepsy (Reutens 
and Berkovic 1992), and progressive myoclonic epilepsy (Reutens et al., 1993). 
Based on a large cohort of 89 normal subjects (ages range 12 to 49 years) using a circular coil and 
abductor digiti minimum (ADM) recordings, Reutens and coworkers (Reutens et al., 1993) found 
a mean CMT of 55.8  12.9 (SD). Because of the large normal range, CMT is more useful for 
statistically comparing groups of patients and normal subjects rather than for determining 
abnormalities in individual cases. 
 
1.11.3. Short-interval Intracortical Inhibition 
Short-interval intracortical inhibition (SICI) was first reported by Kujirai and colleagues (Kujirai 
et al., 1993). 
They applied both stimuli through the same coil to the motor cortex hand area and found that a 
small subthreshold conditioning stimulus could suppress the response to a later suprathreshold test 
stimulus if the interval between stimuli was less than 5 ms (figure 21). Because the conditioning 
stimulus was below AMT, the investigators suggested that the interaction was occurring at a 
cortical level and the conditioning stimulus was suppressing the recruitment of descending volleys 
by the test stimulus. Direct recordings of descending volleys have confirmed this (Di Lazzaro et 
al., 2004). A small conditioning stimulus that itself evokes no descending activity suppresses late 
I waves if the interval between the stimuli is between 1 to 5 ms. The I1 wave is virtually 
unaffected, with the most sensitive wave being the I3 and later volleys (figure 22). 
  
   
 Figure 21 – Paired-pulse intracortical          Figure 22 – Epidural Volleys (left) and EMG  
       inhibition (Rothwell, 2005)   responses (right) (Rothwell, 2005) 
 
Because the I1-wave is unaffected, the results suggest that inhibition does not modify directly the 
excitability of pyramidal neurons. It seems more likely that the inhibition in this paradigm results 
from reduced excitability of inputs responsible for I waves. 
The threshold for producing SICI (i.e., minimum intensity of S1 needed to reduce the response to 
S2) is remarkably low and averages about 70% of the active motor threshold in any individual 
(Orth et al., 2003). Increasing the intensity of S1 initially leads to increased inhibition, but this 
peaks at about 90% to 100%. Higher intensities give a smaller effect and eventually lead to 
facilitation. The later effect is thought to be caused by recruitment of descending corticospinal 
volleys at intensities above AMT that produce subthreshold excitation of spinal motor neurons. 
Although the threshold for inhibition is remarkably similar in different individuals (at least when 
expressed as a percent of that individual’s AMT), the increase of inhibition at higher intensities is 
highly variable. This leads to a wide spread in normal values for SICI when measured with the 
usual S1 intensities of 80% to 100% AMT. 
  
There is other piece of evidence that very small S1 stimuli that are below SICI threshold (at 2 to 5 
ms) can nevertheless activate some cortical circuits. Pairs of S1 stimuli separated by intervals of 4 
ms or less can show temporal summation and lead to clear inhibition (Bestmann et al., 2004). The 
time course of this interaction has been suggested to reflect convergence of synaptic inputs onto a 
common inhibitory interneuron that leads to SICI. 
 
1.11.4. Intracortical Facilitation 
Kujirai and coworkers (Kujirai et al., 1993) originally noticed that if the interval between the 
pulses was greater than 6 ms or so, the MEPs evoked by the test stimulus (S2) were weakly 
facilitated for at least 10 ms. This is now known as intracortical facilitation (ICF). The threshold 
for ICF is higher than that for SICI, and unlike SICI, it is sensitive to the direction of the current 
induced by S1, being maximal with a PA orientation (Ziemann et al., 1996). These features 
suggest that a different mechanism underlies SICI, but more work needs to be done to clarify its 
characteristics fully. There are no studies of how descending corticospinal tract volleys are 
affected by ICF. 
 
1.11.5. Long-interval Intracortical Inhibition  
Long-interval intracortical inhibition (LICI) was first described by Valls-Sole and associates 
(Valls-Sole et al., 1992). They found that a conditioning stimulus strong enough to evoke a MEP 
in the target muscle could suppress a response to a later stimulus of the same intensity if the 
interval was between 50 and 200 ms. Because the excitability of spinal H reflexes had recovered 
at this interval, the effect was though to be cortical, probably the result of activation of GABAB 
receptors (Werhahn et al., 1999). The cortical origin has been confirmed in recordings of 
  
corticospinal volleys (Di Lazzaro et al., 2004). These recordings show that the S1 suppresses the 
size and number of I waves recruited by a S2 given 100 or 150 ms later. The I waves are 
facilitated if the interval between S1 and S2 is 50 ms even though the MEPs are suppressed. 
Presumably, the effect on the MEP results from the refractoriness of spinal motor neurons that 
discharge in response to S1 and other potential spinal mechanisms of inhibition. 
 
1.12. Fatigue  
Fatigue is generally measured as a failure to maintain a given level of physical performance, the 
causes of the failure of humans to perform has intrigued investigators for some time. Mosso 
(1904; cited by Sacco et al., 2005) is generally considered to be the first person to have 
systematically studied muscle fatigue in humans by recording movements of the middle finger 
using an ergograph. He found that the fatigue curves obtained when subjects performed repeated 
contractions could vary considerably. He attributed changes in performance to differences in the 
“nervous arousal” of subjects, who performed better at times when they had greater “mental 
energy”. His conclusion was that muscle fatigue was primarily of nervous origin. Numerous 
studies using isolated muscle preparations have shown that considerable fatigue occurs in the 
absence of nervous input, and it is now generally agreed that under specific conditions all levels 
of the motor pathways can contribute to this phenomenon (Bigland-Ritchie et al., 1995). For 
convenience, these multifactorial processes have been designated central and peripheral fatigue 
mechanisms, with the former referring to changes proximal to the neuromuscular junction. Central 
fatigue can be defined as any loss of voluntary muscle activation associated with exercise. 
Merton (1954) was the first to evaluate the role of central fatigue. In his classic study, the ability 
of subjects to achieve maximum force output of the thumb adductors during a sustained maximum 
  
voluntary contraction (MVC) was evaluated using supramaximal tetanic electrical stimulation of 
the ulnar nerve. He found that no extra force was produced with addition of the stimulus, even 
when voluntary force had declined by more than 50%. He reached the conclusion that fatigue 
occurred only in the muscle, opposite to that of Mosso. Gandevia (2001) has provided a detailed 
view of the role of central mechanisms in muscle fatigue.  
Brasil-Neto and colleagues (1993) were the first to describe the use TMS of the motor cortex to 
study responses to fatigue. They reported a transient decrease in resting motor evoked potential 
(MEP) amplitude of the flexor carpi radialis muscle after a bout of weighted wrist flexions 
repeated to exhaustion. They found a serial decrease in MEP size over the course of four stimuli 
at 5-second intervals. It is important to focus that sustained MVCs are extremely tiring and 
require a high level of motivation and compliance by the subject. For this reason, the duration of 
contractions tend to be short (usually 1 to 2 minutes). Many investigators have subsequently used 
motor nerve stimulation to evaluate voluntary muscle activation, with variations in measurement 
techniques, contraction types, and protocols and muscle groups used. It is now generally accepted 
that the inability to achieve full volitional activation of a muscle may contribute to fatigue in a 
variety of circumstances. 
 
1.13. Effects of Caffeine on the Motor System 
Caffeine has effects on the motor system. These effects may be exerted at distinct levels of the 
nervous system, namely the muscle, the lower motor neuron, the upper motor neuron, or involve 
modulatory effects from other cortical areas. 
 
 
  
1.13.1. Muscle 
It has been described that caffeine has a positive ergogenic effect. This is supported by 3 different 
mechanisms. First, alteration in fat metabolism, as caffeine promotes free fatty acid utilization, 
sparing muscle fiber glycogen reserve; second, a positive direct effect on calcium release from the 
sarcoplasmic reticulum by ryanodine receptors activation, a phenomenon readily observed in the 
muscle preparation but with a non-physiological level of caffeine; third, increasing excitatory 
neurotransmitter activity as a consequence of adenosine receptor antagonism (Graham and Spriet, 
1995; Phillips et al., 1979).  
Caffeine probably has no positive effect on the power of maximal muscle contraction, on the 
twitch contractile properties during exercise or on the M-wave amplitude obtained by electrical 
stimulation of a peripheral nerve (Williams et al., 1987; Meyers and Cafarelli, 2005; Bugyi, 1980; 
Wlliams et al., 1987; Hespel et al., 2002). However, the positive effect of caffeine in endurance 
and reducing fatigue is well demonstrated in a large number of studies (Meyers and Cafarelli, 
2005; Kalmar and Cafarelli 1999; Plaskett and Cafarelli, 2001; Tarnopolsky and Cupido, 2000; 
Jackman et al., 1996; Van Soeren and Graham, 1998). It is not clear if this positive effect is 
related to a more effective muscle contraction. Detailed investigation of the muscle twitch evoked 
in contractions and relaxation times suggests an effect of the drug on sarcoplasmic calcium 
dynamics (Meyers and Cafarelli, 2005). 
 
1.13.2. Lower Motor Neuron 
As mentioned above, caffeine antagonizes adenosine at physiological doses, thus increasing 
excitatory neurotransmitter release which decreases neuron activation threshold (Phillips et al., 
1979). The increased excitability of the serotoninergic neurons of the raphe nuclei may influence 
  
spinal motor neurons as they receive input from descending raphe fibers (Berkowicz and Spector 
1971). As a result, we could expect a greater lower motor neuron (LMN) excitability.  
The monosynaptic Hoffman reflex (H reflex) is an indirect measure of LMN excitability. Two 
studies found no change in the ratio H-reflex/M-wave amplitude in a healthy population after 
caffeine (Kalmar and Cafarelli, 1999; Eke-Okoro 1982). The anticipated reduction of the H-reflex 
amplitude after exercise was not changed after caffeine ingestion (Motl and Dishman 2004). 
However, another study exploring the H-reflex stimulus-response curve to test LMN excitability 
detected significant increased excitability in 7 healthy controls after caffeine administration (6 
mg/kg) (Walton et al., 2003). A different approach is to explore F-waves amplitude and 
peripheral silent period to assess LMN excitability, however, no changes in these measurements 
in a healthy control population after ingestion of 200 mg of caffeine were found (Cerqueira et al., 
2006). 
A different behavior of the LMN could modify recruitment pattern of the motor units during 
muscle contraction, in particular in fatigue. There is no clear evidence that this occurs after 
caffeine consumption (Meyers and Cafarelli, 2005; Kalmar and Cafarelli, 2004). Nonetheless, 
caffeine augments the incidence of self-sustained firing (Walton et al., 2002), which is a 
consequence of increased LMN excitability and related to the presence of plateau potentials. 
Plateau potentials are facilitated by the tonic activity of descending serotoninergic and 
noradrenergic neurons (Crone et al., 1988). This can be a protective mechanism in conditions 
causing muscle fatigue, as an increase in plateau potentials spares the necessary enlargement of 
the excitatory drive to LMN pools (Walton et al., 2002).  
 
  
1.13.3. Upper Motor Neuron 
Transcranial magnetic stimulation (TMS) is the elective method to investigate non-invasively the 
cortical motor area function. The accumulated experience shows that TMS does not change motor 
evoked amplitude (MEP), central conduction time or cortico-motor threshold (Cerqueira et al., 
2006; Kalmar and Cafarelli, 2004; Orth et al., 2005). 
A recent study in 11 healthy subjects disclosed no change of cortical excitability after caffeine (3 
mg/kg), as evaluated by motor threshold (rest and active), short interval intra-cortical inhibition 
(SICI), intra-cortical facilitation, cortical silent period (130, 150, 175% of active threshold) and 
size of the MEP (110%, 125% and 150% rest motor threshold) (Orth et al., 2005). 
As previously mentioned, the cortical silent period (CSP) refers to an interruption of voluntary 
muscle contraction by electrical or magnetic stimulation of the motor cortex. In a previous study, 
our group tested 200 and 400 mg of caffeine in a group of healthy controls and confirmed that 
stimulus intensity 50% above cortical threshold did no modify CSP. However, applying an 
intensity of 10% above threshold, a consistent and statistically significant increase in the CSP, 
between 12-16% in different upper limb muscles, was observed (Cerqueira et al., 2006). It was 
hypothesized that caffeine, by antagonizing excitatory adenosine A2A receptors, could decrease 
the release of GABA and thus reduce GABAergic inhibitory transmission in the motor cortex. 
Alternatively, it could be that the decrease in the CSP after caffeine would not be caused by 
intrinsic changes in neocortical circuitry, but reflect instead modifications in the properties of 
extrinsic cortico-basal-thalamo-cortical pathways that control motor cortex activity (Cerqueira et 
al., 2006). 
 
  
1.13.4. Central Fatigue 
As previously mentioned, the study of central fatigue with TMS is an exciting new area. The CSP 
lengthens and MEP increases during fatiguing contractions (Gandevia, 2001). Immediately after 
exercise, the MEP tested at rest shows an increase as compared to baseline response, a 
phenomenon termed postcontraction facilitation. After this period, the MEP response is markedly 
depressed for as much as half an hour – long-lasting depression. This postfatigue depression 
recovers rapidly during high-intensity muscle contraction. Some authors observed an increased 
post-activation potentiation after caffeine (Kalmar and Cafarelli 2004) but a similar fatigue-
induced rest MEP depression. A more recent study shows that cortically driven twitch can be 
increased by caffeine ingestion, although maximal voluntary activation is not altered during 
fatigue or recovery, suggesting that voluntary activation is not limited by central excitability 
(Gandevia, 2001). Keeping a mild contraction of the target muscle after exercise, the expected 
MEP depression is minimized after caffeine, which reflects its role on the excitability of the motor 
cortex (Gandevia, 2001). 
 
 
 
 
 
 
 
 
 
  
PART II – STUDY PRESENTATION: 
 
2. AIM 
Since caffeine intake consistently decreases CSP following TMS, and a fatiguing contraction 
increases CSP, we raised the hypothesis that the effect of caffeine on the CSP could be attenuated 
after muscle fatigue. The presence, or the absence, of interference with fatigue would be 
important to elucidate the mechanisms that underlie the central effects of caffeine on CSP.  
In addition, we aimed to test in relaxed muscles the effect of caffeine in the short interval intra-
cortical inhibition (SICI) and intra-cortical facilitation (ICF), as described elsewhere, as well as in 
long-interval intra-cortical inhibition (LICI) in which caffeine influence was not tested so far. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3. MATERIALS AND METHODS 
  
3.1. Sample 
Thirteen individuals (3 men and 10 women , mean age 27.5±3.3 years, ranging from 20 to 31) 
working at the Faculty of Medicine, University of Lisbon and at the Hospital de Santa Maria, 
were volunteers in this study. A structured questionnaire was applied by the same observer to all 
subjects, in order to appraise socio-demographic characteristics as well as caffeine consumption 
and smoking habits. Height and weight of the participants were registered to allow calculation of 
body mass index (BMI).  
The inclusion criterion was age range between 20 and 40 and informed consent. 
The exclusion criteria were the presence of cardiac pacemakers, preceding neurosurgical 
procedures, history of epilepsy, neuromuscular disorder, or drug intake that could affect cortical 
excitability, and pregnancy (Cerqueira et al., 2006). 
It should be noted that participants were accepted independently of their caffeine intake habits. 
 
3.2. Study Design  
The study was performed at the Faculty of Medicine, University of Lisbon and the protocol 
approved by the local Ethics Committee. 
All investigations started at the same hour (9 am). Subjects were asked to abstain from caffeine-
containing drinks and foods for 24 hours before the evaluation. On arrival the participants were 
subjected to the experimental electrophysiological protocol. Following the first session they took 
a capsule containing caffeine (200 mg) per os. After one hour interval, the participants underwent 
the same set of electrophysiological tests. The capsules were prepared at the hospital pharmacy. 
  
3.3. Neurophysiology  
For magnetic stimulation a Mag2 magnetic stimulator (Medtronic, Skovlunde, Denmark) and a 
regular sized round coil with a biphasic pulse were used. This device was equipped with a twin-
mode facility to permit double-stimulations paradigms. The electromyographic signal was 
registered and analyzed using a Counterpoint EMG machine (Dantec, Skovlunde, Denmark). Left 
ulnar nerve-ADM system was studied in each subject in the two sessions. Motor responses were 
recorded with surface electrodes (Ag-AgCl) using a belly-tendon montage, with a filter setting of 
20 Hz – 10 KHz.  
 
3.3.1. Threshold and motor evoked potential determination 
The center of the coil was positioned flat over the vertex, but moved as necessary to obtain a 
maximal response at the lowest stimulus intensity. The subjects were asked to keep the hand 
relaxed during the investigation. Voluntary activation of motor units in the ADM was monitored 
through the surface electrodes by the audio system of the EMG device. We defined the resting 
MEP threshold in 5% increments of maximal stimulator output, from an initial stimulus intensity 
of 5%, as the minimum stimulus intensity that evoked at least 5 responses larger than 100 V in 
10 stimuli (Rossini et al.,. 1994). For recording the MEP latency and amplitude the stimulus 
intensity was set at 2% above threshold. In each subject, five to ten consistent responses were 
obtained, with an interstimulus interval of at least 30 seconds. MEP amplitude was estimated 
peak-to-peak from the largest response recorded.  
 
 
  
3.3.2. Paired Pulse Paradigm  
In each individual, the test stimulus intensity of 2% above threshold was chosen. For short-
interval intracortical inhibition (SICI) (Chen, 2004). A conditioning stimuli was set at 0.8 motor 
threshold and the test stimuli was applied 4 ms later. For short-interval intracortical facilitation 
(SICF) (Chen, 2004) the conditioning stimuli was set at motor threshold and the test stimuli 
applied 15 ms later. For long-interval intracortical inhibition (LICI) (Chen, 2004) the conditioning 
stimuli was set at motor threshold and the test stimulus applied 100 ms later. For each paradigm 
the amplitude of the test response was averaged from 10 consecutive paired-stimuli.  
 
3.3.3. Muscle Fatigue 
The subjects were asked to perform full maximal isometric contraction of the left ADM muscle 
for 20 seconds to record EMG signal which was submitted online to power spectrum analysis to 
obtain the mean frequency of the signal. After 1 minute rest, the subjects were verbally stimulated 
to mantain a maximal isometric contraction of the left ADM muscle for 2 minutes. At the end of 
this period and during contraction a power spectrum analysis was again obtained and the median 
frequency registered.  
 
3.3.4. Cortical Silent Period 
Immediately following the exercise protocol the subject was permitted to rest for 15 seconds, and 
then a new short period of left ADM maximal contraction was requested once again. This was 
monitored on screen and through a loudspeaker. The motor cortex was stimulated at 10% above 
threshold in ten consecutive tests, with at least 30 seconds between tests. This TMS stimulus was 
followed by a silent period in motor unit activity (CSP) in the ADM recording, defined as the 
  
interval between the motor response and the return of motor unit activity of at least 100 V. The 
shortest CSP in the ten tests was taken as definitive (Cerqueira et al., 2006). In a previous work 
our group has confirmed that the value measured for CSP latency as defined using this method 
has a high interater reliability and shows high correlation to the latency defined with the rectified 
signal (correlation coefficient > 0.9 for both) (figures 23 and 24) (Cerqueira et al., 2006). 
   
Figure 23. Cortical silent period recording before caffeine      Figure 24. Cortical silent period recording after caffeine 
 
3.4. Statistical Analysis 
Statistical analyses were carried out with the Statistical Package for the Social Sciences (SPSS) 
software (version 14.0 for Windows). Values are be given as mean ± standard deviation (SD). The 
paired Student’s t test was used to analyse the effects of caffeine on electrophysiological 
parameters in the motor cortex. Repeated measures ANOVA was used to study the effects of both 
fatigue and caffeine on the median frequency of the responses spectrum. The absence or presence 
of fatigue was considered in the within-subjects analysis, and the effect of caffeine in the 
between-subjects analysis. P values <0.05 were considered statistically significant. 
 
  
4. RESULTS 
 
4.1. Demographic Characteristics 
Ten female and three male volunteers were studied (see Table 1). Nine were regular and moderate 
coffee consumers and four were non-consumers, although one of these four non-consumers had 
coca cola. Just one of the females was a smoker. 
 
 N Minimum Maximum Mean Std. Deviation 
Age (years) 13 20 31 27,7 3,4 
Weight (kg) 13 53 79 63,3 7,9 
Height (cm) 13 153 186 171 8,6 
Nº coffees (per day) 13 0 7 2,00 2,2 
Table 1. Demographic characteristics 
 
One of the subjects had felt tremor during all day after the experiment, it has been considered a 
side effect of the amount of caffeine given. Two other subjects felt a significantly deprivation of 
caffeine, but one of them said that the headache was gone after the intake of the pills in the 
experiment.  
 
4.2. Electrophysiological Results 
Electrophysiological results are summarised in Table 2. 
The contraction protocol applied in this study was effective in inducing fatigue as evaluated by 
subject symptoms and the change of the median frequency of the EMG electrical signal. Fatigue 
caused a decrease on the median frequency of the motor response 85,6  17,1 Hz to 60,0  17,5 
  
Hz before caffeine (P=0,001) and decrease from 78,8  18,8 Hz to 58,8  15,5 Hz after caffeine 
(P=0,001). However, there was no effect of caffeine on the median frequency of the motor 
response (P=0,127) and no interaction between fatigue and caffeine intake (P=0,274). 
 
 Table 2. Electrophysiological results 
* Student’s t test, comparison of the mean values before and after caffeine intake 
** Repeated Measurements ANOVA test, effect of caffeine (between-subjects analysis) 
*** Repeated Measurements ANOVA test, effect of fatigue (within-subjects analysis) 
 
 
Groups 
 
N 
Before caffeine intake 
Mean  SD 
(Min-Max) 
One hour after caffeine intake 
Mean  SD 
(Min-Max) 
 
P value 
  Rest Fatigue Rest Fatigue  
Cortical 
threshold (%) 
13 49,4  5,5 
(41-56) 
 48,6  5,0 
(41-59) 
 0,370* 
Median 
Frequency  
13 85,6  17,1 
(66 – 122) 
60,0  17,5 
(40 – 98) 
78,8  18,8 
(62 – 135) 
58,8  15,5 
(31 – 90) 
0.127** 
0.001*** 
Amplitude (µV) 13 249,4  183,0 
(70 – 610) 
 304,5  206,5 
(82 – 646) 
 0,252* 
Short-interval 
intracortical 
inhibition 
(SICI)(4 ms) 
(%) 
 
13 
 
87,5  16,3 
(46,4 – 100) 
  
83,8  24,5 
(21,8 – 100) 
  
0,657* 
Intracortical 
facilitation 
(ICF) (15 ms) 
(%) 
13 835,6  1086,3 
(-77,1 – 3542) 
 510,4  421,5 
(-82,5 – 1325,6) 
  
0,3297* 
Long-interval 
intracortical 
inhibition 
(LICI) (100 ms) 
(%) 
 
13 
 
77,7  37,5 
(-18,1 – 100) 
  
49,0  68,6 
(-137,7 – 100) 
  
0,201* 
 
CSP (ms) 
13  214,0  43,7 
(150 – 324) 
 177,5  44.4 
(110 – 251) 
0.004* 
  
In spite of the persistence of the fatigue effect, caffeine could still decrease the CSP elicited under 
fatigue conditions as previously shown under resting conditions. Thus, when applying a stimulus 
intensity of 10% above threshold, the CSP obtained in fatigue conditions was decreased after 
caffeine intake (177,5  44.4 ms), in comparison with the control value before caffeine (214,0  
43,7 ms, P=0,004). 
As shown in Table 2, the threshold, SICI, ICF and LICI were not significantly changed by 
caffeine intake. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
5. DISCUSSION 
 
A remarkably consistent effect for caffeine on the CSP studied by TMS was previously described 
by our group (Cerqueira et al, 2006). This effect of caffeine was even proposed as a biomarker 
for the central effects of caffeine. CSP is thought to be a complex phenomenon, involving spinal 
mechanisms at the beginning and cortical mechanisms at the end of the process, and ultimately 
reflects the GABAergic inhibitory transmission at cortical interneurons. Experimental 
manipulation of GABAB receptors, which are inhibitory autoreceptors, is known to modulate the 
CSP (Inghilleri et al., 1996; Priori et al., 1994; Roick et al., 1993; Ziemann et al., 1996). In this 
context, caffeine might interfere with GABAergic neurotransmission in different ways (Cerqueira 
et al, 2006). It was proposed that caffeine, by antagonizing A2A receptors, could inhibit the 
release of GABA, thus reduce GABAergic inhibitory transmission in the motor cortex, and hence 
decrease the CSP (Cerqueira et al, 2006). Experimental support for this possibility comes from 
the excitatory effect for adenosine A2A receptors described on GABA release in the hippocampus 
(Cunha and Ribeiro, 2000). However, the alternative possibility that caffeine could decrease the 
CSP by modifying the properties of extrinsic cortico-basal-thalamo-cortical pathways that control 
motor cortex activity could not be ruled out. Adenosine A2A receptors are found in brain areas 
rich in dopamine such as the basal ganglia, where they are associated with D2 dopamine receptors 
(Ferre et al., 1997; Fisone et al. 2004) and any significant changes induced by caffeine within the 
basal ganglia would very likely exert a downstream effect on the motor cortex. 
 
In the present work, taking into account that the fatiguing contraction physiologically increases 
CSP in the target muscle by a build-up of intracortical inhibition (Gandevia, 2001; Taylor et al. 
  
1996) and that caffeine has known ergogenic properties and reduces the CSP, we tested whether 
the effect of caffeine on the CSP might be prevented in a fatigued muscle. The fatigue protocol 
applied in this study was effective, as confirmed by the significant decrease of the median 
frequency of the ADM electrical sign. This reflects the decrease in the muscle fiber conduction 
velocity (Lindström et al., 1970) as well as the synchronization of the motor units (Bigland-
Ritchie et al., 1981). Caffeine did not prevent the decrease of the median frequency of the ADM 
electrical sign using this simple fatigue protocol. Remarkably, the magnitude of CSP reduction 
observed for caffeine in the ADM fatigued muscle (17%) was similar to the one previously 
observed in the ADM rested muscle (21%) (Cerqueira et al, 2006). Apparently, fatigue is 
potentiating intracortical inhibition (increasing CSP) and caffeine is attenuating intracortical 
inhibition (decreasing CSP) by mechanisms that are distinct and do not interact in the 
experimental conditions tested. 
 
Our findings regarding the effects of caffeine on threshold, SICI and ICF essentially confirm 
previous results (Orth et al., 2005; Cerqueira et al, 2006). As mentioned above, the threshold 
reflects the excitability of the motor neurons or the associated interneurons, and SICI and ICF 
result from the activity of the cortical interneurons as mediated by GABAA and glutamate, 
respectively (Kujirai et al., 1993). The effect of caffeine on LICI was addressed here for the first 
time. Since both LICI and CSP result from a cortical inhibition, probably mediated by 
GABAergic neurotransmission and regulated by GABAB receptors (Werhahn et al., 1999), one 
might anticipate that caffeine could cause parallel changes on both LICI and CSP. However, 
caffeine, as discussed above, reduced the CSP, but did not modify the LICI significantly. This 
may signify that the mechanisms involved in both inhibitory phenomena are probably different 
  
(Udupa et al., Epub ahead of print). Another possibility would be that the CSP would be more 
sensitive than LICI to reflect changes mediated by GABAB receptors. To this regard, it is 
interesting to consider again the effects of fatigue. Concerning LICI, as it happens with the CSP, 
there is also a dissociation between the effects of fatigue and the effects of caffeine. Fatiguing 
contraction is known to reduce LICI (Benwell et al., 2007) whereas caffeine does not modify 
LICI (as shown in the present study).  
In conclusion, the present findings suggest that caffeine does not counteract centrally the effects 
of fatigue. Caffeine decreases and fatigue increases the CSP by mechanisms that do not interact 
and are thus are probably distinct, and caffeine does not affect, whereas the fatigue reduces, the 
LICI. 
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